Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FCFN5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,950
Award facts
- Contract value 100% obligated
- $10,949.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,949.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on January 2, 2026, with an ultimate completion date of January 26, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999 through December 31, 2036.
DMS Pharmaceutical Group has maintained substantial federal contracting activity as a critical supplier within the Department of Defense pharmaceutical supply chain, with delivery orders ranging from under $100 to over $115,000 across multiple therapeutic categories and product lines. The company's comprehensive product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables serving military healthcare facilities worldwide. This delivery order reflects the company's ongoing role as a regional prime vendor contractor under the broader $30.3 billion PPV-G GEN V acquisition strategy, positioning it to fulfill diverse and specialized pharmaceutical requirements for Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCFN5?
SPE2DR26FCFN5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FCFN5 worth?
The government has obligated $10,950 on SPE2DR26FCFN5.
Is contract SPE2DR26FCFN5 an order under another contract?
Yes. SPE2DR26FCFN5 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFN5 competed?
The extent of competition for SPE2DR26FCFN5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award